Covance Not Cooling...
Health Care: Health Services
Abiomed Inc. (ABMD: NASDAQ)
$23.32 0.22 | 0.93%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 23.33 |
| 52 Week High | 24.93 |
| 52 Week Low | 11.80 |
| Avg. Daily Vol. (Mil) | 0.47 |
| Beta (3 year) | 1.75 |
| Share Related Items | |
| Mkt Cap (Mil) | 899.36 |
| Shares Out (Mil) | 38.56 |
| Float (Mil) | 31.63 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.50 |
| Current Ratio | 5.20 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 63.00 |
| Price/Sales | 5.69 |
| Price/Book | 6.61 |
| Price/Cash Flow | 52.40 |
| Per Share Data | |
| Earnings | 0.37 |
| Sales | 4.10 |
| Book Value | 3.53 |
| Cash Flow | 0.45 |
| Business Summary | |
|---|---|
| Abiomed, Inc. is a provider of mechanical circulatory support devices and it offers a continuum of care in heart recovery to heart failure patients. | |
| General Information | |
| 22 Cherry Hill Drive
Danvers, MA 01923 |
|
| www.abiomed.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 397 | |
| CEO: Mr. Michael R. Minogue | |
| Short Interest | |
| Current Month (Mil) | 7.61 |
| Previous Month (Mil) | 7.54 |
| Short Interest Ratio (Days) | 22.40 |
| Management Effectiveness | |
| Return on Equity | 10.20 |
| Return on Assets | 8.40 |
| Return on Investments | 10.20 |
| Profitability | |
| Gross Margin | 82.40 |
| EBIT Margin | 10.30 |
| Profit Margin | 9.50 |
Portfolios with ABMD
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Top Morningstar M&A Stoc...
- ContributorStocks Rising On Unusual Vo...
Latest ABMD Headlines from TheStreet
- Abiomed To Present At UBS Global Health Care Conference 05.17.13 | 08:05 am
- Abiomed To Present At Bank Of America Merrill Lynch 2013 Health Care Conference 05.08.13 | 08:05 am
- Abiomed To Present At Bank Of America Merrill Lynch 2013 Smid Cap Conference 05.03.13 | 08:05 am
- Abiomed Announces Fourth Quarter GAAP EPS Of $0.09 On Record Revenue And Patients Supported 05.02.13 | 07:05 am
- Abiomed Announces Publication Of Protect II Cost Effectiveness Study In American Health & Drug Benefits Journal 05.01.13 | 08:05 am
- 3 Stocks Spiking on Big Volume 04.17.13 | 03:04 pm
- ABIOMED Breaks Above 200-Day Moving Average - Bullish For ABMD 04.17.13 | 11:04 am
- Abiomed Announces Preliminary Fourth Quarter Revenue Of $43.7 Million, Driven By Record Number Of Patients Supported 04.17.13 | 07:04 am
- Abiomed Announces First Impella RP Patient Enrolled In Recover Right Study 04.01.13 | 08:04 am
- Abiomed To Present At Barclays Global Healthcare Conference 03.07.13 | 08:03 am
Press Releases for ABMD
- SHAREHOLDER ALERT: Levi & Korsinsky Launches An Investigation Into Possible Breaches Of Fiduciary Duty By Abiomed, Inc. - Business Wire 01.17.13 | 12:01 pm
- Hagens Berman Reminds Abiomed Investors Only Six Days Remain Before Jan. 15, 2013, Lead Plaintiff Deadline In Class-action Lawsuit - Business Wire 01.09.13 | 03:01 pm
- Investor Alert: Hagens Berman Advises Investors Of Pending Deadlines In Abiomed, Inc., Align Technology, Inc., And St. Jude Medical, Inc. Class Actions - PR Newswire 01.07.13 | 03:01 pm
- The Shuman Law Firm Announces The Filing Of A Securities Class Action Lawsuit Against Abiomed, Inc. - Business Wire 12.21.12 | 03:12 pm
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Of Arbitron Inc. (ARB) And Class Action Against Hi-Crush Partners LP (HCLP), Align Technology, Inc. (ALGN) And Abiomed, Inc. (ABMD) - PR Newswire 12.19.12 | 12:12 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In ABIOMED, Inc. To Contact The Firm - PR Newswire 12.17.12 | 04:12 pm
- Investor Alert: Following Food And Drug Administration Panel Vote, Hagens Berman Reminds Abiomed, Inc. Investors Of Jan. 15, 2013, Lead Plaintiff Deadline In Class-Action Lawsuit - Business Wire 12.07.12 | 06:12 am
- Milberg LLP Announces Pendency Of Class Action Lawsuits Filed Against Abiomed, Inc. (ABMD) -- AbiomedLawsuit.com - Business Wire 12.06.12 | 11:12 am
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Blyth, Inc. (BTH), Align Technology, Inc. (ALGN) And Abiomed, Inc. (ABMD) And Investigation Of Peregrine Pharmaceuticals, Inc. (PPHM) - PR Newswire 12.05.12 | 01:12 pm
- Newman Ferrara LLP Announces That A Securities Fraud Class Action Lawsuit Has Been Filed Against ABIOMED, Inc. - Business Wire 12.04.12 | 03:12 pm
Partner Headlines for ABMD
- Mid-Day Market Update: Markets Largely Flat, Groupon Boosts - Benzinga 12.07.12 | 01:12 pm
- Abiomed Says Class Action Lawsuit Without Merit; Intends to Defend Vigorously - Benzinga 11.16.12 | 06:11 pm
- Abiomed Beats 2Q Ests, Profit Jumps - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- FDA Approves Abiomed's Impella CP - Analyst Blog - NASDAQ 09.11.12 | 11:09 pm
- FDA Approves Abiomed's Impella CP - Analyst Blog - Zacks 09.11.12 | 07:09 pm
- Abiomed Reaffirmed at Neutral - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
- Abiomed's Heart Pumps Pound Q1 Expectations - Investor's Business Daily 08.02.12 | 05:08 pm
- Pre-Market Earnings Report for August 2, 2012 : APA, AEE, ANSS, ARIA, APO, ALE, AB, ABMD, AYR, AVD, ARQL, AGEN - NASDAQ 08.01.12 | 08:08 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 07.19.12 | 09:07 am
- Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX - GuruFocus 07.17.12 | 01:07 pm
